Literature DB >> 16387952

Epidemiology and costs of chronic obstructive pulmonary disease.

K R Chapman1, D M Mannino, J B Soriano, P A Vermeire, A S Buist, M J Thun, C Connell, A Jemal, T A Lee, M Miravitlles, S Aldington, R Beasley.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16387952     DOI： 10.1183/09031936.06.00024505

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  187 in total

1.  Comorbidity and chronic conditions in the National Social Life, Health and Aging Project (NSHAP), Wave 2.

Authors:  Terrie Vasilopoulos; Ashwin Kotwal; Megan J Huisingh-Scheetz; Linda J Waite; Martha K McClintock; William Dale
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

Review 2.  Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease.

Authors:  Sarah K Brode; Simon C Ling; Kenneth R Chapman
Journal:  CMAJ       Date:  2012-07-03       Impact factor: 8.262

3.  Breathing new life into lung transplantation therapy.

Authors:  Angela Panoskaltsis-Mortari; Daniel J Weiss
Journal:  Mol Ther       Date:  2010-09       Impact factor: 11.454

4.  Diagnosis of airway obstruction or restrictive spirometric patterns by multiclass support vector machines.

Authors:  Deniz Sahin; Elif Derya Ubeyli; Gul Ilbay; Murat Sahin; Alisan Burak Yasar
Journal:  J Med Syst       Date:  2009-05-12       Impact factor: 4.460

Review 5.  Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).

Authors:  Han Ni; Aung Htet; Soe Moe
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

6.  Caring for the burden of COPD.

Authors:  P M A Calverley
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

7.  Effect of chronic obstructive pulmonary disease on swallowing function in stroke patients.

Authors:  Gun Woong Park; Suk Kyoung Kim; Chang Hwa Lee; Chung Reen Kim; Ho Joong Jeong; Dong Kyu Kim
Journal:  Ann Rehabil Med       Date:  2015-04-24

8.  Randomized, double-blind, placebo-controlled superiority trial of the Yiqigubiao pill for the treatment of patients with chronic obstructive pulmonary disease at a stable stage.

Authors:  Feng-Sen Li; Yan-Li Zhang; Zheng Li; Dan Xu; Chun-Yan Liao; Huan Ma; Li Gong; Jun Su; Qi Sun; Qian Xu; Zhen Gao; Ling Wang; Jing Jing; Jing Wang; Min Jiang; Ge Tian; Bilal Hasan
Journal:  Exp Ther Med       Date:  2016-09-06       Impact factor: 2.447

9.  Integrated interdisciplinary care for patients with chronic obstructive pulmonary disease reduces emergency department visits, admissions and costs: a quality assurance study.

Authors:  Esther Dajczman; Chantal Robitaille; Pierre Ernst; Andrew Michael Hirsch; Norman Wolkove; David Small; Judy Bianco; Hartley Stern; Mark Palayew
Journal:  Can Respir J       Date:  2013 Sep-Oct       Impact factor: 2.409

Review 10.  Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies.

Authors:  Maria B Ospina; Donald C Voaklander; Michael K Stickland; Malcolm King; Ambikaipakan Senthilselvan; Brian H Rowe
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.